Axogen Inc. (AXGN)

Axogen Inc. Aktie (AXGN) Neueste Nachrichten

AxoGen (AXGN) Reports Q1 Loss, Lags Revenue Estimates

Zacks Investment Research

908 Devices Inc. (MASS) Reports Q1 Loss, Tops Revenue Estimates

Zacks Investment Research

Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™

GlobeNewswire Inc.

Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024

GlobeNewswire Inc.

Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Benzinga

Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial Results

GlobeNewswire Inc.

Zacks.com featured highlights Protagonist Therapeutics, AxoGen, Western Digital and Phunware

Zacks Investment Research

Ekso Bionics (EKSO) Reports Q4 Loss, Tops Revenue Estimates

Zacks Investment Research

4 Must-Buy Stocks for Remarkable Earnings Acceleration

Zacks Investment Research

AxoGen (AXGN) Is a Great Choice for 'Trend' Investors, Here's Why

Zacks Investment Research

AxoGen, Inc. (AXGN) Hit a 52 Week High, Can the Run Continue?

Zacks Investment Research

Zacks.com featured highlights AxoGen, Western Digital and Gen Digital

Zacks Investment Research

3 Best Stocks to Buy for Remarkable Earnings Acceleration

Zacks Investment Research

Axogen, Inc. to Report 2023 Fourth Quarter and Full-Year Financial Results on March 5, 2024

GlobeNewswire Inc.

Here's Why Momentum in AxoGen (AXGN) Should Keep going

Zacks Investment Research

Is AxoGen (AXGN) Stock Outpacing Its Medical Peers This Year?

Zacks Investment Research

Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire Inc.

Zacks.com featured highlights include AxoGen, Western Digital, Accolade and Credo Technology Group

Zacks Investment Research

4 Top Stocks That Flaunt Solid Earnings Acceleration

Zacks Investment Research

Here's What Could Help AxoGen (AXGN) Maintain Its Recent Price Strength

Zacks Investment Research

Axogen, Inc. Announces Positive Topline Results from REPOSE, a Prospective, Randomized Clinical Trial of Axoguard Nerve Cap

GlobeNewswire Inc.

Zacks.com featured highlights include Aspen Aerogels, AxoGen and Credo Technology Group

Zacks Investment Research

3 Stocks Worth a Look for Solid Earnings Acceleration

Zacks Investment Research

Crude Oil Rises Over 2%; Constellation Brands Posts Downbeat Sales

Benzinga

Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Benzinga

Greenbrier Posts Upbeat Earnings, Joins Kura Sushi USA, AxoGen And Other Big Stocks Moving Higher On Friday

Benzinga

Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2023

GlobeNewswire Inc.

Axogen Announces Plan for Leadership Transition with CEO Karen Zaderej to Retire from Company by January 2025

GlobeNewswire Inc.

Axogen Announces Promotions on Research and Development Team

GlobeNewswire Inc.

Axogen, Inc. Appoints Kathy Weiler to its Board of Directors

GlobeNewswire Inc.

Axogen Announces Transition of Finance Team Leadership

GlobeNewswire Inc.

Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire Inc.